🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

33+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 13 of 33 recruiting trials for “transient-myeloproliferative-syndrome”

RecruitingNCT05850273 ↗

Mechanism of Action of Interferon in the Treatment of Myeloproliferative Neoplasms

👨‍⚕️ Florence Pasquier, MD,PhD, florence.pasquier@gustaveroussy.fr📍 1 site📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT05732961 ↗

Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms

👨‍⚕️ Rami Komrokji, MD, Moffitt Cancer Center📍 1 site📅 Started Feb 2023View details ↗
RecruitingNCT07410247 ↗

MPN Childhood Registry

👨‍⚕️ Axel Karow, MD, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany📍 1 site📅 Started Jan 2023View details ↗
RecruitingNCT07204392 ↗

Unveiling the Germline Predisposition to Myeloproliferative Neoplasms

🏥 Fondazione IRCCS Policlinico San Matteo di Pavia📍 1 site📅 Started Jun 2022View details ↗
NARecruitingNCT05190653 ↗

Early Integration of Palliative and Supportive Care in Cellular Therapy

👨‍⚕️ Reanne Booker, PhD(c), AHS Calgary📍 1 site📅 Started Apr 2022View details ↗
NARecruitingNCT04898790 ↗

Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant

👨‍⚕️ Thuy Koll, MD, University of Nebraska📍 1 site📅 Started Nov 2021View details ↗
Phase 1, PHASE2RecruitingNCT04771130 ↗

A Study of BGB-11417 in Participants With Myeloid Malignancies

🏥 BeiGene📍 46 sites📅 Started May 2021View details ↗
RecruitingNCT04014374 ↗

Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab

🏥 Kyowa Kirin, Inc.📍 1 site📅 Started Sep 2019View details ↗
Phase 1RecruitingNCT03326921 ↗

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

👨‍⚕️ Elizabeth Krakow, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Feb 2018View details ↗
EARLY_Phase 1RecruitingNCT06643221 ↗

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

🏥 University of Arizona📍 1 site📅 Started Jan 2018View details ↗
RecruitingNCT03328650 ↗

Clinical Outcomes of the ALPS Proximal Humerus Plating System

🏥 Vanderbilt University Medical Center📍 1 site📅 Started Aug 2017View details ↗
Phase 1RecruitingNCT02508038 ↗

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

👨‍⚕️ Christian Capitini, MD, University of Wisconsin, Madison📍 1 site📅 Started Feb 2016View details ↗
RecruitingNCT00935090 ↗

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

👨‍⚕️ Anthony F. Shields, MD, PhD, Barbara Ann Karmanos Cancer Institute📍 1 site📅 Started Sep 2009View details ↗
← PreviousPage 2 of 2

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →